{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:07:43Z","timestamp":1793927263568,"version":"4.8.0"},"reference-count":63,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Seizures and movement disorders (MDs) are distinct neurological conditions presenting with abnormal movements. Despite sharing an overlap in phenomenology, these movements have different origins. In order to explore the overlaps and the narrow boundaries between these two conditions, we performed a review of the literature to explore the risk of seizures in MDs. We discussed the mimics and chameleons including MDs that look like seizure (eg, paroxysmal dyskinesia, status dystonicus) and seizures that look like MDs (eg,<jats:italic>epilepsia partialis continua<\/jats:italic>, nocturnal frontal lobe epilepsy). Additionally, we examined the therapeutic challenges as well as the anatomical and chemical pathways relevant in the interplay between epilepsy and MDs. Finally, we proposed an algorithm to guide clinicians towards the final diagnosis of conditions characterised by the co-occurrence of MDs and seizures.<\/jats:p>","DOI":"10.1136\/jnnp-2018-320039","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T22:16:29Z","timestamp":1550873789000},"page":"920-928","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches"],"prefix":"10.1136","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-0892","authenticated-orcid":false,"given":"Maria Eliza","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ruiz-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-7419","authenticated-orcid":false,"given":"Roberto","family":"Erro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Privitera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-0180","authenticated-orcid":false,"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2020050722344754000_90.8.920.1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/B978-0-444-53486-6.00049-1","article-title":"Movement disorders","volume":"136","author":"Stoessl","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"2020050722344754000_90.8.920.2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13670"},{"key":"2020050722344754000_90.8.920.3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.26527","article-title":"Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord"},{"key":"2020050722344754000_90.8.920.4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"2020050722344754000_90.8.920.5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eplepsyres.2013.11.013","article-title":"Parkinson's disease: less epileptic seizures, more status epilepticus","volume":"108","author":"Feddersen","year":"2014","journal-title":"Epilepsy Res"},{"key":"2020050722344754000_90.8.920.6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.25157","article-title":"Parkinson disease and the risk of epileptic seizures","volume":"83","author":"Gruntz","year":"2018","journal-title":"Ann Neurol"},{"key":"2020050722344754000_90.8.920.7","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i29.2859"},{"key":"2020050722344754000_90.8.920.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2010.01.007"},{"key":"2020050722344754000_90.8.920.9","doi-asserted-by":"crossref","unstructured":"Savino E , Soavi C , Capatti E , et al . Bilateral strio-pallido-dentate calcinosis (Fahr's disease): report of seven cases and revision of literature. BMC Neurol 2016;16.doi:10.1186\/s12883-016-0693-1","DOI":"10.1186\/s12883-016-0693-1"},{"key":"2020050722344754000_90.8.920.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.12.024","article-title":"Deconstructing Fahr's disease\/syndrome of brain calcification in the era of new genes","volume":"37","author":"Batla","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"2020050722344754000_90.8.920.11","doi-asserted-by":"crossref","unstructured":"Nie S , Chen G , Cao X , et al . Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2014;9.doi:10.1186\/s13023-014-0179-4","DOI":"10.1186\/s13023-014-0179-4"},{"key":"2020050722344754000_90.8.920.12","doi-asserted-by":"crossref","unstructured":"Schneider SA . Neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep 2016;16.doi:10.1007\/s11910-015-0608-3","DOI":"10.1007\/s11910-015-0608-3"},{"key":"2020050722344754000_90.8.920.13","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3283632d90"},{"key":"2020050722344754000_90.8.920.14","doi-asserted-by":"crossref","unstructured":"Bates GP , Dorsey R , Gusella JF , et al . Huntington disease. Nat Rev Dis Primers 2015;1.doi:10.1038\/nrdp.2015.5","DOI":"10.1038\/nrdp.2015.5"},{"key":"2020050722344754000_90.8.920.15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/epi.13318","article-title":"Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation","volume":"57","author":"Benninger","year":"2016","journal-title":"Epilepsia"},{"key":"2020050722344754000_90.8.920.16","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12350"},{"key":"2020050722344754000_90.8.920.17","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-51892-7.00041-3"},{"key":"2020050722344754000_90.8.920.18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1684\/epd.2016.0860","article-title":"Autosomal dominant cortical tremor, myoclonus and epilepsy","volume":"18","author":"Striano","year":"2016","journal-title":"Epileptic Disord"},{"key":"2020050722344754000_90.8.920.19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ridd.2015.10.005","article-title":"Increased risk of epilepsy in children with tourette syndrome: a population-based case-control study","volume":"51-52","author":"Wong","year":"2016","journal-title":"Res Dev Disabil"},{"key":"2020050722344754000_90.8.920.20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpeds.2016.10.079","article-title":"Alternating hemiplegia of childhood as a new presentation of adenylate cyclase 5-mutation-associated disease: a report of two cases","volume":"181","author":"Westenberger","year":"2017","journal-title":"J Pediatr"},{"key":"2020050722344754000_90.8.920.21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu142"},{"key":"2020050722344754000_90.8.920.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708712"},{"key":"2020050722344754000_90.8.920.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"2020050722344754000_90.8.920.24","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1212\/WNL.0000000000002359","article-title":"Teaching video neuroImages: faciobrachial dystonic seizures: pathognomonic phenomenology","volume":"86","author":"Schmerler","year":"2016","journal-title":"Neurology"},{"key":"2020050722344754000_90.8.920.25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"2020050722344754000_90.8.920.26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABA A receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"2020050722344754000_90.8.920.27","doi-asserted-by":"crossref","unstructured":"Kirshner HS . Hashimoto's encephalopathy: a brief review. Curr Neurol Neurosci Rep 2014;14.doi:10.1007\/s11910-014-0476-2","DOI":"10.1007\/s11910-014-0476-2"},{"key":"2020050722344754000_90.8.920.28","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52910-7.00039-8"},{"key":"2020050722344754000_90.8.920.29","doi-asserted-by":"crossref","unstructured":"Manix M , Kalakoti P , Henry M , et al . Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus 2015;39.doi:10.3171\/2015.8.FOCUS15328","DOI":"10.3171\/2015.8.FOCUS15328"},{"key":"2020050722344754000_90.8.920.30","first-page":"1","article-title":"Creutzfeldt-Jakob disease presenting as expressive aphasia and nonconvulsive status epilepticus","volume":"2018","author":"Mahboob","year":"2018","journal-title":"Case Rep Crit Care"},{"key":"2020050722344754000_90.8.920.31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2015.06.032","article-title":"Hemifacial spasm: the past, present and future","volume":"356","author":"Chaudhry","year":"2015","journal-title":"J Neurol Sci"},{"key":"2020050722344754000_90.8.920.32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.yebeh.2007.09.002","article-title":"Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua","volume":"12","author":"Espay","year":"2008","journal-title":"Epilepsy Behav"},{"key":"2020050722344754000_90.8.920.33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ana.24593","article-title":"Prevalence and determinants of periodic limb movements in the general population","volume":"79","author":"Haba-Rubio","year":"2016","journal-title":"Ann Neurol"},{"key":"2020050722344754000_90.8.920.34","doi-asserted-by":"crossref","unstructured":"Nguyen-Michel V-H , Solano O , Lambrecq V , et al . Complex periodic limb movements during sleep or partial epileptic seizures? Neurology 2015;85.doi:10.1212\/WNL.0000000000002224","DOI":"10.1212\/WNL.0000000000002224"},{"key":"2020050722344754000_90.8.920.35","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mds.27207","article-title":"Rethinking status dystonicus","volume":"32","author":"Ruiz-Lopez","year":"2017","journal-title":"Mov Disord"},{"key":"2020050722344754000_90.8.920.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311693"},{"key":"2020050722344754000_90.8.920.37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/mds.26901","article-title":"The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: channelopathies, synaptopathies, and transportopathies","volume":"32","author":"Erro","year":"2017","journal-title":"Mov Disord"},{"key":"2020050722344754000_90.8.920.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv310"},{"key":"2020050722344754000_90.8.920.39","doi-asserted-by":"crossref","unstructured":"Pearson TS , Akman C , Hinton VJ , et al . Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (GLUT1 Ds). Curr Neurol Neurosci Rep 2013;13.doi:10.1007\/s11910-013-0342-7","DOI":"10.1007\/s11910-013-0342-7"},{"key":"2020050722344754000_90.8.920.40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.26610","article-title":"Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency","volume":"31","author":"Olgiati","year":"2016","journal-title":"Mov Disord"},{"key":"2020050722344754000_90.8.920.41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2012.03709.x","article-title":"The startle syndromes: physiology and treatment","volume":"53 Suppl 7","author":"Dreissen","year":"2012","journal-title":"Epilepsia"},{"key":"2020050722344754000_90.8.920.42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26598"},{"key":"2020050722344754000_90.8.920.43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clineuro.2018.06.004","article-title":"Epilepsia partialis continua: correlation of semiology, outcome and electrophysiologic features","volume":"171","author":"Atmaca","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"Supplement","key":"2020050722344754000_90.8.920.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmr.IJMR_57_15","article-title":"Spectrum of hyperosmolar hyperglycaemic state in neurology practice","volume":"146","author":"Misra","year":"2017","journal-title":"Indian J Med Res"},{"key":"2020050722344754000_90.8.920.45","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/WNL.0000000000002666","article-title":"Definition and diagnostic criteria of sleep-related hypermotor epilepsy","volume":"86","author":"Tinuper","year":"2016","journal-title":"Neurology"},{"key":"2020050722344754000_90.8.920.46","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2014-000994"},{"key":"2020050722344754000_90.8.920.47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1684\/epd.2016.0843","article-title":"SCARB2\/LIMP2 deficiency in action myoclonus-renal failure syndrome","volume":"18","author":"Dibbens","year":"2016","journal-title":"Epileptic Disord"},{"key":"2020050722344754000_90.8.920.48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1684\/epd.2016.0848","article-title":"GOSR2: a progressive myoclonus epilepsy gene","volume":"18","author":"Dibbens","year":"2016","journal-title":"Epileptic Disord"},{"key":"2020050722344754000_90.8.920.49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.03.019","article-title":"Recessive AFG3L2 mutation causes progressive microcephaly, early onset seizures, spasticity, and basal ganglia involvement","volume":"71","author":"Eskandrani","year":"2017","journal-title":"Pediatr Neurol"},{"key":"2020050722344754000_90.8.920.50","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-310864"},{"key":"2020050722344754000_90.8.920.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70260-6"},{"key":"2020050722344754000_90.8.920.52","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1212\/WNL.0000000000000521","article-title":"Antecollis and levodopa-responsive parkinsonism are late features of dravet syndrome","volume":"82","author":"Fasano","year":"2014","journal-title":"Neurology"},{"key":"2020050722344754000_90.8.920.53","doi-asserted-by":"crossref","unstructured":"Levy A , Chen R . Myoclonus: pathophysiology and treatment options. Curr Treat Options Neurol 2016;18.doi:10.1007\/s11940-016-0404-7","DOI":"10.1007\/s11940-016-0404-7"},{"key":"2020050722344754000_90.8.920.54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-016-0341-8","article-title":"Valproate-Associated parkinsonism: a critical review of the literature","volume":"30","author":"Brugger","year":"2016","journal-title":"CNS Drugs"},{"key":"2020050722344754000_90.8.920.55","doi-asserted-by":"crossref","unstructured":"Nevitt SJ , Sudell M , Weston J , et al . Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev 2017;12.doi:10.1002\/14651858.CD011412.pub3","DOI":"10.1002\/14651858.CD011412.pub3"},{"key":"2020050722344754000_90.8.920.56","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez Ot\u00e1rula KA , Ugarnes G , Rossi M , et al . Phenytoin-induced chorea: drug interaction or genetic predisposition? Clin Neuropharmacol 2016;39.doi:10.1097\/WNF.0000000000000140","DOI":"10.1097\/WNF.0000000000000140"},{"key":"2020050722344754000_90.8.920.57","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","article-title":"Essential tremor","volume":"379","author":"Haubenberger","year":"2018","journal-title":"N Engl J Med"},{"key":"2020050722344754000_90.8.920.58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.parkreldis.2012.03.006","article-title":"Paroxysmal kinesigenic dyskinesia: cortical or non-cortical origin","volume":"18","author":"van Strien","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"2020050722344754000_90.8.920.59","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn113"},{"key":"2020050722344754000_90.8.920.60","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww012"},{"key":"2020050722344754000_90.8.920.61","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0808-z"},{"key":"2020050722344754000_90.8.920.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.02.051"},{"key":"2020050722344754000_90.8.920.63","doi-asserted-by":"crossref","unstructured":"Wagnon JL , Barker BS , Ottolini M , et al . Loss-of-function variants of SCN8A in intellectual disability without seizures. Neurol Genet 2017;3.doi:10.1212\/NXG.0000000000000170","DOI":"10.1212\/NXG.0000000000000170"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2018-320039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:50:09Z","timestamp":1606564209000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2018-320039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,11]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/jnnp-2018-320039"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2018-320039","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]}}}